Oncogenesis is associated with intestinal dysbiosis, and stool shotgun metagenomic
sequencing in individuals with this condition might constitute a non-invasive approach for …

Immunotherapy has emerged as a robust approach against cancer, yet its efficacy has
varied among individuals, accompanied by the occurrence of immune-related adverse …

Immunotherapy has emerged as an effective treatment for various types of cancers. Recent
studies have highlighted a significant correlation between the gut microbiome and patients' …

Obesity is a disease with high potential for fatality. It perfectly fits the disease definition, as
cancer does. This is because it damages body structure and functions, both mechanically …

Background There is a crosstalk between gut microbiota (GM) and cancer immunotherapy
(CI). The purpose of this study is to use bibliometric analysis to identify the highly cited …

Simple Summary Immunotherapy-based combinations represent the front-line standard of
care for metastatic clear cell renal cell carcinoma (mccRCC) patients. These combinations …

Immunotherapy for non-small cell lung cancer (NSCLC) has advanced considerably over
the past two decades. In particular, immune checkpoint inhibitors are widely used for treating …

Immune checkpoint inhibitors (ICIs) have revolutionised oncology and are now standard‐of‐
care for the treatment of a wide variety of solid neoplasms. However, tumour responses …

Abstract Background Immune checkpoint inhibitors (ICIs) have dramatically shifted the
therapeutic paradigm of extensive‐stage small cell lung cancer (ES‐SCLC). Antibiotic (ATB) …

Background Immune checkpoint inhibitors (ICIs) such as programmed cell death protein-1
(PD-1) inhibitors or PD-1 ligand-1 (PD-L1) inhibitors have led to remarkable improvement in …